TLR9 signaling defines distinct prognostic subsets in CLL

Dimitar G. Efremov, Riccardo Bomben, Stefania Gobessi, Valter Gattei

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Chronic lymphocytic leukemia (CLL) is a common B-cell malignancy characterized by a highly variable clinical course. The behavior of the disease is believed to be influenced by microenvironmental signals that regulate the proliferation and survival of the malignant B-cells. Signals transduced through Toll-like-receptor-9 (TLR9) may play a particularly important role, as they could drive the expansion of a subset of cells that express B-cell receptors reactive with DNA or DNA-containing complexes. Interestingly, leukemic cells from patients with aggressive disease respond more effectively to TLR9 stimulation than their less aggressive counterparts, suggesting that the capacity to respond to TLR9 signals can define distinct prognostic subsets in CLL. The exact mechanism(s) accounting for the variability in the response to TLR9 engagement are still unclear, although important differences have been observed between prognostic groups in terms of downstream signaling events and gene- and miRNA-expression profiles. Understanding the mechanism(s) that underlie the different TLR9 responses should provide further insight in the pathophysiology of CLL and may lead to the identification of novel targets for therapeutic intervention.

Original languageEnglish
Pages (from-to)371-386
Number of pages16
JournalFrontiers in Bioscience
Volume18
Issue number1
DOIs
Publication statusPublished - Jan 1 2013

Fingerprint

Toll-Like Receptor 9
B-Cell Chronic Lymphocytic Leukemia
B-Lymphocytes
Cells
DNA
MicroRNAs
Transcriptome
Genes
Neoplasms

Keywords

  • Chronic lymphocytic leukemia
  • MicroRNA
  • Prognosis
  • Signal transduction
  • Toll-like receptor 9

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Immunology and Microbiology(all)
  • Medicine(all)

Cite this

TLR9 signaling defines distinct prognostic subsets in CLL. / Efremov, Dimitar G.; Bomben, Riccardo; Gobessi, Stefania; Gattei, Valter.

In: Frontiers in Bioscience, Vol. 18, No. 1, 01.01.2013, p. 371-386.

Research output: Contribution to journalArticle

Efremov, Dimitar G. ; Bomben, Riccardo ; Gobessi, Stefania ; Gattei, Valter. / TLR9 signaling defines distinct prognostic subsets in CLL. In: Frontiers in Bioscience. 2013 ; Vol. 18, No. 1. pp. 371-386.
@article{5f1d04b6a6f54c819256ae86c09ce74a,
title = "TLR9 signaling defines distinct prognostic subsets in CLL",
abstract = "Chronic lymphocytic leukemia (CLL) is a common B-cell malignancy characterized by a highly variable clinical course. The behavior of the disease is believed to be influenced by microenvironmental signals that regulate the proliferation and survival of the malignant B-cells. Signals transduced through Toll-like-receptor-9 (TLR9) may play a particularly important role, as they could drive the expansion of a subset of cells that express B-cell receptors reactive with DNA or DNA-containing complexes. Interestingly, leukemic cells from patients with aggressive disease respond more effectively to TLR9 stimulation than their less aggressive counterparts, suggesting that the capacity to respond to TLR9 signals can define distinct prognostic subsets in CLL. The exact mechanism(s) accounting for the variability in the response to TLR9 engagement are still unclear, although important differences have been observed between prognostic groups in terms of downstream signaling events and gene- and miRNA-expression profiles. Understanding the mechanism(s) that underlie the different TLR9 responses should provide further insight in the pathophysiology of CLL and may lead to the identification of novel targets for therapeutic intervention.",
keywords = "Chronic lymphocytic leukemia, MicroRNA, Prognosis, Signal transduction, Toll-like receptor 9",
author = "Efremov, {Dimitar G.} and Riccardo Bomben and Stefania Gobessi and Valter Gattei",
year = "2013",
month = "1",
day = "1",
doi = "10.2741/4108",
language = "English",
volume = "18",
pages = "371--386",
journal = "Frontiers in Bioscience - Landmark",
issn = "1093-9946",
publisher = "Frontiers in Bioscience",
number = "1",

}

TY - JOUR

T1 - TLR9 signaling defines distinct prognostic subsets in CLL

AU - Efremov, Dimitar G.

AU - Bomben, Riccardo

AU - Gobessi, Stefania

AU - Gattei, Valter

PY - 2013/1/1

Y1 - 2013/1/1

N2 - Chronic lymphocytic leukemia (CLL) is a common B-cell malignancy characterized by a highly variable clinical course. The behavior of the disease is believed to be influenced by microenvironmental signals that regulate the proliferation and survival of the malignant B-cells. Signals transduced through Toll-like-receptor-9 (TLR9) may play a particularly important role, as they could drive the expansion of a subset of cells that express B-cell receptors reactive with DNA or DNA-containing complexes. Interestingly, leukemic cells from patients with aggressive disease respond more effectively to TLR9 stimulation than their less aggressive counterparts, suggesting that the capacity to respond to TLR9 signals can define distinct prognostic subsets in CLL. The exact mechanism(s) accounting for the variability in the response to TLR9 engagement are still unclear, although important differences have been observed between prognostic groups in terms of downstream signaling events and gene- and miRNA-expression profiles. Understanding the mechanism(s) that underlie the different TLR9 responses should provide further insight in the pathophysiology of CLL and may lead to the identification of novel targets for therapeutic intervention.

AB - Chronic lymphocytic leukemia (CLL) is a common B-cell malignancy characterized by a highly variable clinical course. The behavior of the disease is believed to be influenced by microenvironmental signals that regulate the proliferation and survival of the malignant B-cells. Signals transduced through Toll-like-receptor-9 (TLR9) may play a particularly important role, as they could drive the expansion of a subset of cells that express B-cell receptors reactive with DNA or DNA-containing complexes. Interestingly, leukemic cells from patients with aggressive disease respond more effectively to TLR9 stimulation than their less aggressive counterparts, suggesting that the capacity to respond to TLR9 signals can define distinct prognostic subsets in CLL. The exact mechanism(s) accounting for the variability in the response to TLR9 engagement are still unclear, although important differences have been observed between prognostic groups in terms of downstream signaling events and gene- and miRNA-expression profiles. Understanding the mechanism(s) that underlie the different TLR9 responses should provide further insight in the pathophysiology of CLL and may lead to the identification of novel targets for therapeutic intervention.

KW - Chronic lymphocytic leukemia

KW - MicroRNA

KW - Prognosis

KW - Signal transduction

KW - Toll-like receptor 9

UR - http://www.scopus.com/inward/record.url?scp=84875980968&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84875980968&partnerID=8YFLogxK

U2 - 10.2741/4108

DO - 10.2741/4108

M3 - Article

C2 - 23276930

AN - SCOPUS:84875980968

VL - 18

SP - 371

EP - 386

JO - Frontiers in Bioscience - Landmark

JF - Frontiers in Bioscience - Landmark

SN - 1093-9946

IS - 1

ER -